🔎 Trials Near Me

Home › Ovarian Cancer › Pennsylvania › Allentown

Ovarian Cancer clinical trials in Allentown, PA

5 studies for Ovarian Cancer are looking for participants at sites in and around Allentown (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem · 6 mi away
All ages · All sexes · Updated Oct 5, 2026 · NCT05564377

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

RecruitingPhase 3
  • St. Luke's University Health Network, Bethlehem · 6 mi away
Ages 18 and older · Women · Updated Sep 14, 2026 · NCT04575935

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Saint Luke's Cancer Center - Allentown, Allentown
  • Saint Luke's University Hospital-Bethlehem Campus, Bethlehem · 6 mi away
  • and 3 more
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

RecruitingPhase 3
  • St. Lukes University Health Network, Bethlehem · 6 mi away
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Allentown

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.